If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
109.50    0.00 (0.00%)
Bid:
107.00
Ask:
112.00
Spread: 5.00 (4.673%)
Market Cap: £14.77m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Trading Update

13 Jul 2022 07:00

RNS Number : 2575S
Itaconix PLC
13 July 2022
 

13 July 2022

 

Itaconix plc

("Itaconix" or the "Company")

Trading Update

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products, is pleased to provide a trading update for the half year to 30 June 2022.

The Company produced record unaudited revenues of $3.0 million for the first six months of the year. These revenues reflect 124% growth over the first half of 2021 and 149% growth from the second half of 2021. In addition, they are 118% of the full year revenues for 2021 and 93% of the full year revenues for 2020. The Company is in a strong position to meet market expectations for revenues in 2022.

Cleaning applications led overall revenue growth for the period with a 212% increase over the first half of 2021 as Itaconix polymers found important new usage in European detergent formulations and continued to gain share in North America. The Company had strong volumes throughout the first six months and is starting the second half with a solid order book. 

These gains were offset by lower revenues from beauty and hygiene applications in the first half of 2022 compared to the first half of 2021. The Company made good progress with new accounts and usages in both areas, but they were not enough to balance against lower order volumes from partners.

Overall gross profit margin for the first six months was lower than in previous periods due to the mix of product revenues and the timing of passing on higher raw material costs. The Company expects a more favourable blend of product mix and raw material prices in the second half of the year, together with some sales price increases.

Net unaudited cash as at 30 June 2022 was $0.9 million.

John R. Shaw, CEO of Itaconix, commented:

"Engagement with customers on decarbonizing everyday products with our innovative ingredients is paying off with a solid base of recurring revenues and a strong pipeline of new revenue opportunities.

"We are seeing increased traction for our plant-based cleaning ingredients as existing customers expand into more retailers and important new customers bring new formulations to market. We expect to see at least one new European detergent product on the market this year, and possibly even more. With these breakthroughs and steady advances in North America, we expect continued progress through in to 2023.

"As the revenues and success of our current products become more certain, we are setting our sights on bigger and broader ingredient opportunities from our proprietary technology platform. We are working with potential customers on new products that they can bring to the hygiene market with our plant-based superabsorbent.

"We are very pleased to see our business progress to this stage, are excited about the opportunities in front of us to grow the Company, and are now in the process of strengthening our Board for our next level of growth."

Capital Markets Webinar

An online Capital Markets webinar was recently held on 6 July 2022 and investors can access the video presentation, which gives more detail on product development and market opportunities, at the following link: www.edisongroup.com/itaconix-capital-markets-day/. The video will also be available shortly in the investor section of Itaconix's website.

 

 

 

- Ends -

 

For further information please contact:

Itaconix plc

+1 603 775 4400

John R. Shaw / Laura Denner

Belvedere Communications

+44 (0) 74 070 23147

John West / Llew Angus

finnCap

+44 (0) 20 7220 0500

Ed Frisby / Abigail Kelly / Milesh Hindocha (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's contributions to the global low carbon economy are recognised by the London Stock Exchange's Green Economy Mark.

www.itaconix.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGGGDRXGBDGDX
Date   Source Headline
9th Feb 202211:00 amRNSPrice Monitoring Extension
9th Feb 20227:00 amRNSFirst Trial for Sustainable Superabsorbent
3rd Feb 20227:00 amRNSNew Patent Filed for Plant-Based Ingredient
26th Jan 20222:05 pmRNSSecond Price Monitoring Extn
26th Jan 20222:00 pmRNSPrice Monitoring Extension
26th Jan 20227:00 amRNSTrading Update
10th Jan 20227:15 amRNSInitiation of Research
22nd Dec 20217:00 amRNSFirst Order for New Use in Sustainable Fashion
21st Dec 20219:05 amRNSSecond Price Monitoring Extn
21st Dec 20219:00 amRNSPrice Monitoring Extension
21st Dec 20217:00 amRNSStatement re Production Resumption
9th Dec 202111:06 amRNSSecond Price Monitoring Extn
9th Dec 202111:00 amRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSProduction Interruption from Storm Damage
1st Oct 20214:41 pmRNSSecond Price Monitoring Extn
1st Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20212:05 pmRNSSecond Price Monitoring Extn
1st Oct 20212:00 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
23rd Sep 20214:41 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:36 pmRNSPrice Monitoring Extension
23rd Sep 20217:00 amRNSNotice of Interim Results & Investor Presentation
16th Sep 202112:13 pmRNSSecond Price Monitoring Extn
16th Sep 202112:12 pmRNSSecond Price Monitoring Extn
16th Sep 202112:12 pmRNSPrice Monitoring Extension
14th Sep 20214:41 pmRNSSecond Price Monitoring Extn
14th Sep 20214:36 pmRNSPrice Monitoring Extension
14th Sep 202111:06 amRNSSecond Price Monitoring Extn
14th Sep 202111:01 amRNSPrice Monitoring Extension
9th Sep 20217:00 amRNSFirst EU Order for Latest Detergent Ingredient
26th Aug 20217:00 amRNSChange of Adviser
27th Jul 20219:05 amRNSSecond Price Monitoring Extn
27th Jul 20219:00 amRNSPrice Monitoring Extension
27th Jul 20217:00 amRNSTrading Statement
19th Jul 202111:05 amRNSSecond Price Monitoring Extn
19th Jul 202111:00 amRNSPrice Monitoring Extension
19th Jul 20217:00 amRNSRemoval of US Securities Law Restrictions
24th Jun 20213:18 pmRNSResult of Annual General Meeting
18th Jun 20217:00 amRNSChanges to AGM Arrangements, Investor Presentation
9th Jun 20219:00 amRNSPrice Monitoring Extension
9th Jun 20217:00 amRNSCompleted New Funding with Institutional Investors
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSTrading Update
27th May 20217:00 amRNSNotice of AGM
20th May 20214:41 pmRNSSecond Price Monitoring Extn
20th May 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSItaconix receives the LSE's Green Economy Mark

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.